A Facilitated Access Program to Provide Everolimus (RAD) Maintenance for Patients Completing Therapy in RAD Trials in Solid Organ Transplantation

Summary

Facilitated access to everolimus until it is commercially available and reimbursable by appropriate parties

Timeline

Start

—

Primary completion

—

Completion

—

Drugs

Indications